Generate Investment Management Ltd Makes New $5.33 Million Investment in HCA Healthcare, Inc. $HCA

Generate Investment Management Ltd purchased a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA) during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 12,500 shares of the company’s stock, valued at approximately $5,328,000.

A number of other large investors have also recently made changes to their positions in the stock. Ameriflex Group Inc. bought a new stake in shares of HCA Healthcare during the 2nd quarter valued at $27,000. Chung Wu Investment Group LLC purchased a new stake in shares of HCA Healthcare in the second quarter worth about $27,000. Clearstead Trust LLC grew its stake in HCA Healthcare by 311.8% during the second quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock valued at $27,000 after acquiring an additional 53 shares in the last quarter. Harbor Capital Advisors Inc. boosted its holdings in HCA Healthcare by 82.9% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 75 shares of the company’s stock valued at $32,000 after purchasing an additional 34 shares during the period. Finally, Twin Peaks Wealth Advisors LLC bought a new position in shares of HCA Healthcare in the second quarter worth $40,000. 62.73% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on HCA shares. Royal Bank Of Canada raised their price target on HCA Healthcare from $482.00 to $525.00 and gave the company an “outperform” rating in a report on Friday, December 19th. Zacks Research cut shares of HCA Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Thursday, November 27th. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of HCA Healthcare in a report on Monday, October 27th. Wells Fargo & Company raised their price target on HCA Healthcare from $412.00 to $431.00 and gave the company an “equal weight” rating in a research report on Thursday, November 13th. Finally, Robert W. Baird raised their price objective on HCA Healthcare from $423.00 to $450.00 and gave the company a “neutral” rating in a report on Thursday, December 11th. Fourteen research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $479.00.

HCA Healthcare Stock Performance

HCA Healthcare stock opened at $473.13 on Wednesday. The stock has a market cap of $107.96 billion, a price-to-earnings ratio of 18.29, a PEG ratio of 1.40 and a beta of 1.36. The stock’s 50 day simple moving average is $477.30 and its two-hundred day simple moving average is $422.24. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $520.00.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, October 24th. The company reported $6.96 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.64 by $1.32. The business had revenue of $19.16 billion during the quarter, compared to the consensus estimate of $18.55 billion. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The firm’s quarterly revenue was up 9.6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $4.90 earnings per share. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. On average, analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, December 29th. Shareholders of record on Monday, December 15th were paid a dividend of $0.72 per share. The ex-dividend date was Monday, December 15th. This represents a $2.88 dividend on an annualized basis and a yield of 0.6%. HCA Healthcare’s payout ratio is presently 11.13%.

Insider Buying and Selling at HCA Healthcare

In other news, EVP Michael R. Mcalevey sold 3,892 shares of HCA Healthcare stock in a transaction dated Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total value of $1,843,990.68. Following the completion of the transaction, the executive vice president owned 3,487 shares of the company’s stock, valued at $1,652,105.73. The trade was a 52.74% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 1.30% of the stock is owned by insiders.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.